NERVOUS SYSTEM DAMAGE IN HIV INFECTION AND AIDS

Egamberdiev Jasur Mukhammadi Oʻgʻli; Qodirov Umid Arzikulovich; Khakimova  Sokhiba Ziyadulloyevna

doi:10.61796/jmgcb.v2i2.1176

Authors

Egamberdiev Jasur Mukhammadi Oʻgʻli
egamberdiev@gmail.com
Samarkand State Medical University, Uzbekistan
Qodirov Umid Arzikulovich Samarkand State Medical University, Uzbekistan
Khakimova Sokhiba Ziyadulloyevna Samarkand State Medical University, Uzbekistan

Vol. 2 No. 2 (2025): Journal of Medical Genetics and Clinical Biology

Articles

December 11, 2024

Downloads

View Article

Abstract
How to Cite
Metrics
References
License

Objective: This study aims to explore the neurological complications of HIV infection, specifically the impact of HIV on the nervous system, including the role of the glycoprotein gp120 in neuronal damage. Methods: A review of HIV-related neurological impairments, focusing on the mechanisms of viral infection and the consequences on glial and neuronal cells, was conducted. The study examines the direct and indirect damage caused by the virus and associated factors such as opportunistic infections, tumors, and the effects of antiretroviral drugs. Results: : The study finds that HIV infection affects approximately one in every hundred cells in brain tissue, significantly impacting glial cells, neurons, and other cells possessing the CD4 receptor. HIV damages these cells through direct infection and by the destructive effects of the gp120 glycoprotein, which leads to membrane lysis and neurotoxic consequences such as an increased Ca2+ ion load in astrocytes. Novelty: This research highlights the critical role of gp120 in the pathogenesis of HIV-induced neuronal damage, specifically its interference with neuroleukin and the glutamate retention mechanisms in astrocytes, which are key to understanding HIV-related neurological disorders.

Jasur Mukhammadi Oʻgʻli, E., Umid Arzikulovich, Q., & Sokhiba Ziyadulloyevna, K. (2024). NERVOUS SYSTEM DAMAGE IN HIV INFECTION AND AIDS. Journal of Medical Genetics and Clinical Biology, 2(2), 71–78. https://doi.org/10.61796/jmgcb.v2i2.1176

Download Citation

S. Andryev et al., "Experience with the use of memantine in the treatment of cognitive disorders," Science and Innovation, vol. 2, no. D11, pp. 282-288, 2023.

S. Antsiborov et al., "Association of dopaminergic receptors of peripheral blood lymphocytes with a risk of developing antipsychotic extrapyramidal diseases," Science and Innovation, vol. 2, no. D11, pp. 29-35, 2023.

R. Asanova et al., "Features of the treatment of patients with mental disorders and cardiovascular pathology," Science and Innovation, vol. 2, no. D12, pp. 545-550, 2023.

M. Begbudiyev et al., "Integration of psychiatric care into primary care," Science and Innovation, vol. 2, no. D12, pp. 551-557, 2023.

B. Bo’Riyev et al., "Features of clinical and psychopathological examination of young children," Science and Innovation, vol. 2, no. D12, pp. 558-563, 2023.

Y. Borisova et al., "Concomitant mental disorders and social functioning of adults with high-functioning autism/Asperger syndrome," Science and Innovation, vol. 2, no. D11, pp. 36-41, 2023.

U. A. Ivanovich et al., "Efficacy and tolerance of pharmacotherapy with antidepressants in non-psychotic depressions in combination with chronic brain ischemia," Science and Innovation, vol. 2, no. 12, pp. 409-414, 2023.

R. A. Nikolaevich et al., "Comparative effectiveness of treatment of somatoform diseases in psychotherapeutic practice," Science and Innovation, vol. 2, no. 12, pp. 898-903, 2023.

A. Novikov et al., "Alcohol dependence and manifestation of autoaggressive behavior in patients of different types," Science and Innovation, vol. 2, no. D11, pp. 413-419, 2023.

Y. Pachulia et al., "Assessment of the effect of psychopathic disorders on the dynamics of withdrawal syndrome in synthetic cannabinoid addiction," Science and Innovation, vol. 2, no. D12, pp. 240-244, 2023.

Y. Pachulia et al., "Neurobiological indicators of clinical status and prognosis of therapeutic response in patients with paroxysmal schizophrenia," Science and Innovation, vol. 2, no. D12, pp. 385-391, 2023.

A. Pogosov et al., "Multidisciplinary approach to the rehabilitation of patients with somatized personality development," Science and Innovation, vol. 2, no. D12, pp. 245-251, 2023.

A. Pogosov et al., "Rational choice of pharmacotherapy for senile dementia," Science and Innovation, vol. 2, no. D12, pp. 230-235, 2023.

S. Pogosov et al., "Gnostic disorders and their compensation in neuropsychological syndrome of vascular cognitive disorders in old age," Science and Innovation, vol. 2, no. D12, pp. 258-264, 2023.

S. Pogosov et al., "Prevention of adolescent drug abuse and prevention of iatrogenia during prophylaxis," Science and Innovation, vol. 2, no. D12, pp. 392-397, 2023.

S. Pogosov et al., "Psychogenetic properties of drug patients as risk factors for the formation of addiction," Science and Innovation, vol. 2, no. D12, pp. 186-191, 2023.

N. Prostyakova et al., "Changes in the postpsychotic period after acute polymorphic disorder," Science and Innovation, vol. 2, no. D12, pp. 356-360, 2023.

N. Prostyakova et al., "Issues of professional ethics in the treatment and management of patients with late dementia," Science and Innovation, vol. 2, no. D12, pp. 158-165, 2023.

N. Prostyakova et al., "Sadness and loss reactions as a risk of forming a relationship together," Science and Innovation, vol. 2, no. D12, pp. 252-257, 2023.

N. Prostyakova et al., "Strategy for early diagnosis with cardiovascular disease-isomatized mental disorders," Science and Innovation, vol. 2, no. D12, pp. 166-172, 2023.

A. Rotanov et al., "Comparative effectiveness of treatment of somatoform diseases in psychotherapeutic practice," Science and Innovation, vol. 2, no. D12, pp. 267-272, 2023.

A. Rotanov et al., "Diagnosis of depressive and suicidal spectrum disorders in students of a secondary special education institution," Science and Innovation, vol. 2, no. D11, pp. 309-315, 2023.

A. Rotanov et al., "Elderly epilepsy: neurophysiological aspects of non-psychotic mental disorders," Science and Innovation, vol. 2, no. D12, pp. 192-197, 2023.

A. Rotanov et al., "Social, socio-cultural and behavioral risk factors for the spread of HIV infection," Science and Innovation, vol. 2, no. D11, pp. 49-55, 2023.

A. Rotanov et al., "Suicide and epidemiology and risk factors in oncological diseases," Science and Innovation, vol. 2, no. D12, pp. 398-403, 2023.

V. Sedenkov et al., "Clinical and socio-demographic characteristics of elderly patients with suicide attempts," Science and Innovation, vol. 2, no. D12, pp. 273-277, 2023.

V. Sedenkov et al., "Modern methods of diagnosing depressive disorders in neurotic and affective disorders," Science and Innovation, vol. 2, no. D12, pp. 361-366, 2023.